Target: Alphatec Holdings, Inc. (NASDAQ: ATEC; SEC CIK 0001350653)
Research date: 26 October 2026
Entity boundary: Alphatec Holdings, Inc., its identified operating subsidiaries, and its documented controlling or influential principals.
Direct Defence Contracting & Procurement
Corporate identity and operating scope
Alphatec Holdings, Inc. is a Delaware-incorporated medical-technology company headquartered in Carlsbad, California. Its SEC registration classifies it within surgical and medical instruments and apparatus manufacturing.1
The company’s 2024 Form 10-K identifies Alphatec Spine, Inc., SafeOp Surgical, Inc., and EOS imaging S.A.S. as wholly owned operating subsidiaries. It describes the business as developing technology for the surgical treatment of spinal disorders.2
Its Form 10-Q for the quarter ended 30 June 2026 confirms continuing commercial operations and identifies Patrick S. Miles as Chairman and Chief Executive Officer and J. Todd Koning as Chief Financial Officer. The report was filed on 4 August 2026.3, 4
Israeli Ministry of Defence and security-agency procurement
No public evidence identified of a contract, tender award, framework agreement, memorandum of understanding, or equipment-supply arrangement between the identified Alphatec group and the Israeli Ministry of Defence, Israel Defence Forces, Israel Prison Service, Israel Border Police, or another Israeli state security body.
Defence directories and exhibitions
No public evidence identified of Alphatec Holdings or its identified operating subsidiaries appearing as suppliers to the Israeli military through SIBAT, Israeli military procurement listings, or an Israeli defence exhibition.
Announcements and joint ventures
The company’s public corporate disclosures describe a spine-surgery technology business. Its February 2026 results announcement identifies the Valence intraoperative platform and continued expansion of its surgical and imaging activities.5
No public evidence identified of an Israeli defence partnership, defence-specific joint venture, military technology-transfer agreement, or cooperation announcement.
Historical international distribution
On 1 September 2016, Alphatec announced completion of the sale of its international operations and distribution channel to Globus Medical. The announcement described Alphatec’s resulting focus on the United States market. This transaction is historical [pre-2020] and does not establish any continuing Alphatec defence relationship.6
Dual-Use Products & Tactical Variants
Medical imaging and surgical AI
On 24 July 2024, Alphatec announced the commercial launch of EOS Insight, using EOS imaging and artificial intelligence for spine-surgery planning. Its identified initial clinical implementation was at OrthoIndy Hospital in the United States.7
The company’s disclosed product portfolio includes spinal implants, imaging equipment, and systems intended to support surgery. These identified medical applications do not themselves establish military-specific design or procurement.2
Alphatec’s February 2026 announcement reported the clearance and release of the Valence intraoperative platform within its spine-surgery business.5
No public evidence identified that EOS Insight, Valence, SafeOp, or another named Alphatec system was purpose-built for kinetic military targeting, fire control, weapon guidance, or kill-chain automation.
Civilian and military distinction
The available corporate descriptions identify clinical functions, including imaging, surgical planning, patient assessment, and intraoperative assistance.8
No public evidence identified that any Alphatec product had been modified under an Israeli military contract or supplied as a designated tactical variant.
Product records
The ICIJ International Medical Devices Database contains historical Alphatec Spine medical-device entries, including records associated with spinal implants. These records establish medical-device regulatory history and do not identify an Israeli defence end-user.9
The database records are historical [pre-2020]; they do not independently establish the current distribution or military use of the devices.9
Export licences and end-user certificates
No public evidence identified of an Israeli military end-user certificate, military-specific export licence, defence-related export classification ruling, or export-control review concerning an identified Alphatec product supplied to Israel.
Heavy Machinery, Construction & Infrastructure
Products and industrial scope
The company’s 2024 annual filing describes a spinal medical-technology business rather than a manufacturer of earthmoving machinery, construction vehicles, demolition equipment, or military engineering platforms.2
The company’s 2026 operating disclosures continue to identify spinal surgery and medical imaging as its principal commercial activities.3
Equipment in occupied territories
No public evidence identified of Alphatec-owned or Alphatec-branded heavy machinery being used for settlement construction, demolition, checkpoint development, military-base construction, or infrastructure works in the West Bank, East Jerusalem, or Golan Heights.
Settlement-business database
The UN Human Rights Council’s September 2025 discussion of the OHCHR settlement-business database described a review of alleged settlement-related activities and the identification of 158 enterprises. This establishes the scope of the institutional screening exercise but does not identify Alphatec as one of those enterprises.10
No public evidence identified establishing Alphatec Holdings, Alphatec Spine, SafeOp, or EOS imaging as a settlement construction contractor or heavy-equipment supplier.
Direct and indirect supply
No public evidence identified of Alphatec equipment reaching an Israeli settlement construction or demolition project through a direct sale, authorised distributor, intermediary, or secondary-market transaction.
Construction and engineering contracts
No public evidence identified of Alphatec participation in construction, engineering, maintenance, or expansion of Israeli military installations, detention facilities, checkpoints, separation-barrier infrastructure, or settlements.
Supply Chain Integration with Defence Primes
Corporate group and relationships
Alphatec’s 2024 Form 10-K describes an operating group centred on Alphatec Spine, SafeOp, and EOS imaging. Its disclosed operating activities concern surgical medical technology.2
The September 2016 sale of international operations to Globus Medical is a documented corporate transaction [pre-2020]. The announcement establishes a transfer of business operations and distribution arrangements but does not establish a military supply relationship with an Israeli defence manufacturer.6
Components supplied to Israeli defence manufacturers
No public evidence identified of component, subsystem, material, or manufacturing-service supply by Alphatec to Elbit Systems, Israel Aerospace Industries, Rafael Advanced Defense Systems, Israel Military Industries, or another Israeli defence prime.
Specific component categories
No public evidence identified of Alphatec supplying optical targeting equipment, military communications components, propulsion equipment, radar components, structural armour, military electronics, guidance systems, or weapon-specific materials to an Israeli defence manufacturer.
Joint development and technology transfer
No public evidence identified of joint development, licensed manufacturing, military research collaboration, co-production, or technology transfer involving Alphatec and an Israeli defence company.
Governance and influential principals
Alphatec’s corporate governance disclosures identify Patrick S. Miles as Chairman and Chief Executive Officer and describe his professional background in the orthopaedic and medical-device industries, including NuVasive, Medtronic Sofamor Danek, and Smith & Nephew.11
The company’s 2026 proxy statement documents its director-election and governance arrangements, providing a primary corporate record for identifying influential board members.12
The company’s June 2026 SEC registration statement identifies corporate signatories, including Patrick S. Miles and J. Todd Koning, and lists company directors involved in the filing.13
Alphatec’s current governance materials provide additional director biographies and committee information. These disclosures do not themselves establish Israeli military-industry appointments or military-channel corporate activity.14
David R. Pelizzon and Squadron Capital appear in Alphatec-related ownership and governance records. The existence of an investment or board relationship does not by itself establish that another investment or activity is attributable to Alphatec.12
Documented related-party supply
Alphatec’s second-quarter 2026 Form 10-Q identifies purchases of inventory from an affiliate of Squadron Capital, LLC. The filing identifies David Pelizzon, President and Director of Squadron Capital, LLC, as a member of Alphatec’s Board of Directors.3
For the three months ended 30 June 2026, Alphatec reported purchases of $5.8 million from the Squadron supplier affiliate. Purchases for the six months ended that date totalled $11.4 million.3
The comparative purchases for the corresponding three- and six-month periods of 2025 were $2.3 million and $5.1 million, respectively.3
The filing identifies these transactions as related-party inventory purchases. It does not identify the inventory as military equipment or establish an Israeli military end-user.3
No public evidence identified establishing that the Squadron supplier affiliate’s documented transactions with Alphatec constituted supply to an Israeli defence manufacturer or Israeli state security body.
Military-channel activities of controlling principals
No public evidence identified of a specific Israeli defence-board appointment, Israeli military-industry equity position, defence-production investment, or military-channel donation attributable to Alphatec through a controlling principal.
Logistical Sustainment & Base Services
Commercial operating model
Alphatec’s 2024 annual report describes product marketing through independent sales agents and direct sales representatives and identifies hospitals and surgical centres as customers of its medical technologies.2
The company’s Form 10-Q for the quarter ended 30 June 2026 confirms continued commercial activity in the medical-technology sector.3
Military installation services
No public evidence identified of Alphatec providing catering, facilities management, fuel, waste services, military transport, telecommunications, maintenance, or other base-support services to Israeli military installations.
Geographic specificity
No public evidence identified of Alphatec supplying military logistical services to installations in the West Bank, East Jerusalem, Golan Heights, Negev, or elsewhere in Israel.
Shipping, freight and port services
No public evidence identified of an Alphatec contract for military freight forwarding, weapons transportation, military cargo handling, Israeli defence-port operations, or another Israeli military logistics service.
The historical sale of Alphatec’s international distribution channel to Globus Medical in 2016 [pre-2020] does not establish continued control over that former distribution network.6
Munitions, Weapons Systems & Strategic Platforms
Business classification
The SEC’s corporate registrant record identifies Alphatec Holdings within the surgical and medical instruments industry.1
Its August 2026 Form 10-Q filing record confirms the continuing SEC reporting identity of the same company.15
Lethal systems
No public evidence identified of Alphatec manufacturing, integrating, servicing, or supplying small arms, artillery, armoured vehicles, combat drones, naval weapons, or other lethal platforms for Israeli forces.
Munitions and precursor materials
No public evidence identified of Alphatec supplying ammunition, explosive ordnance, propellants, warhead components, or munitions precursor materials to Israeli defence customers.
Strategic platforms
No public evidence identified of Alphatec participation in Iron Dome, David’s Sling, Arrow, Israeli combat aircraft, main battle tanks, naval weapons systems, or ballistic missile programmes.
Military targeting AI
The July 2024 EOS Insight announcement describes AI-assisted clinical spine-surgery planning, including medical imaging and patient-specific surgical preparation.7
No public evidence identified of Alphatec software producing military targeting decisions, selecting targets for kinetic attack, controlling weapons, generating strike coordinates, or integrating into Israeli weapon-guidance systems.
Critical components
No public evidence identified of Alphatec supplying military fire-control electronics, radar components, propulsion systems, calibrated weapons guidance, combat sensor systems, or other critical subsystems specifically designed for an Israeli lethal platform.
Export Licensing, Regulatory & Legal History
Public corporate reporting
Alphatec’s fiscal-year 2025 Form 10-K was filed with the SEC on 24 February 2026. The filing record identifies Alphatec Holdings as the registrant and provides the relevant annual reporting period.16
Alphatec filed its first-quarter 2026 Form 10-Q on 5 May 2026. That filing covers the quarterly period ended 31 March 2026.17, 18
The company’s separate second-quarter 2026 Form 10-Q was filed on 4 August 2026 and covers the quarterly period ended 30 June 2026. Its consolidated financial statements present operating results for the three and six months ended 30 June 2026, with comparative periods for 2025.3, 4
The first-quarter filing dated 5 May 2026 and the second-quarter filing dated 4 August 2026 are distinct SEC submissions. The first-quarter filing does not supply the operating results for the quarter ended 30 June 2026.18, 3
Defence export decisions
No public evidence identified of an export licence granted, denied, suspended, or revoked for Alphatec military equipment supplied to an Israeli defence or security end-user.
Embargo and sanctions enforcement
No public evidence identified of an enforcement proceeding against Alphatec concerning an Israeli arms embargo, prohibited military shipment, military export-control violation, or sanctions breach arising from defence trade with Israel.
Legal challenges
No public evidence identified of a judicial review, civil claim, criminal prosecution, or administrative proceeding specifically challenging Alphatec’s alleged defence supply relationship with Israel.
Temporal context
The company’s 2025 annual filing and 2026 quarterly reporting establish corporate activity after the ICJ advisory opinion of 19 July 2024 and the ICC’s November 2024 arrest-warrant decisions. These corporate filings do not establish the existence or continuation of an Israeli military supply relationship.16, 3
No public evidence identified of an Alphatec Israeli defence contract continuing after either legal milestone.
Related-party transaction chronology
The Form 10-Q covering the period ended 30 June 2026 records purchases from a Squadron Capital affiliate during both 2025 and 2026 comparative periods. These transactions establish a documented commercial supply relationship during the periods reported.3
No public evidence identified establishing that the related-party transactions involved Israeli defence procurement or supply to an Israeli military installation.
Civil Society Scrutiny & Documented Investigations
United Nations institutional reporting
The September 2025 OHCHR settlement-database update was discussed at the Human Rights Council’s sixtieth session. The UN meeting record describes the review of business-enterprise allegations involving settlement-related activities and the identification of 158 enterprises.10
The UN Special Rapporteur’s report A/HRC/59/23, “From economy of occupation to economy of genocide”, was published in July 2025. Its publication and official document identity are confirmed by the European Country of Origin Information Network’s bibliographic record.19
No public evidence identified establishing that Alphatec Holdings or its named operating subsidiaries were specifically implicated in a military supply arrangement through either of those reviewed institutional sources.
Specialist NGO investigations
No public evidence identified of a target-specific military supply-chain investigation naming Alphatec Holdings by Who Profits, AFSC Investigate, Amnesty International, Human Rights Watch, Al-Haq, SOMO, BankTrack, B’Tselem, or a comparable specialist organisation.
Boycott and divestment activity
No public evidence identified of an organised campaign specifically targeting Alphatec Holdings for supplying weapons, military equipment, or military services to Israeli forces.
No public evidence identified of a pension fund, sovereign wealth fund, university, or other institution announcing divestment from Alphatec specifically because of verified Israeli defence supply.
Corporate response
No public evidence identified of Alphatec issuing a statement about Israeli defence contracts, cancelling an Israeli military supply agreement, adopting a military end-use restriction concerning Israel, or responding to a substantiated allegation of participation in Israeli military procurement.
Entity-name distinction
A separate business operating as ALPHA TEC describes itself as an Israeli supplier of aesthetic-medicine equipment founded in 2015. Its disclosed business concerns dermatological and cosmetic technologies.20
No public evidence identified establishing that this similarly named company is an Alphatec Holdings subsidiary, licensee, distributor, or controlled affiliate.
Additional ownership and disclosure context
Alphatec’s SEC annual-filing metadata identifies the legal registrant and its continuing public reporting obligations. Those records provide a basis for distinguishing Alphatec Holdings from similarly named businesses.21
The company’s second-quarter 2026 Form 10-Q also provides a primary record of its related-party inventory transactions with a Squadron Capital affiliate, including comparative amounts for 2025 and 2026.3
No public evidence identified establishing an Israeli military relationship through the named controlling principals, disclosed group entities, or historical commercial arrangements reviewed.
Footnotes
-
U.S. Securities and Exchange Commission, Alphatec Holdings, Inc., EDGAR registrant profile, accessed 26 October 2026. https://www.sec.gov/edgar/browse/?CIK=0001350653 ↩ ↩2
-
Alphatec Holdings, Inc., Form 10-K for fiscal year ended 31 December 2024, filed 2025. https://www.sec.gov/Archives/edgar/data/1350653/000095017025027916/atec-20241231.htm ↩ ↩2 ↩3 ↩4 ↩5
-
Alphatec Holdings, Inc., Form 10-Q for period ended 30 June 2026, filed 4 August 2026, SEC accession 0001193125-26-333051. https://www.sec.gov/Archives/edgar/data/1350653/000119312526333051/atec-20260630.htm ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12
-
U.S. Securities and Exchange Commission, Alphatec Holdings, Inc., Form 10-Q filing index for quarterly period ended 30 June 2026, filed 4 August 2026, SEC accession 0001193125-26-333051. https://www.sec.gov/Archives/edgar/data/1350653/000119312526333051/0001193125-26-333051-index.htm ↩ ↩2
-
Alphatec Holdings, Inc., “ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results”, 24 February 2026. https://investors.alphatecspine.com/press-releases/news-details/2026/ATEC-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results/default.aspx ↩ ↩2
-
Alphatec Holdings, Inc., “Alphatec Holdings Completes Sale of International Business to Globus Medical”, 1 September 2016. [pre-2020] https://investors.alphatecspine.com/press-releases/news-details/2016/Alphatec-Holdings-Completes-Sale-of-International-Business-to-Globus-Medical/default.aspx ↩ ↩2 ↩3
-
Alphatec Holdings, Inc., “ATEC Launches EOS Insight, an End-To-End Spine Surgery Platform Powered by EOS Imaging and AI”, 24 July 2024. https://investors.alphatecspine.com/press-releases/news-details/2024/ATEC-Launches-EOS-InsightTM-an-End-To-End-Spine-Surgery-Platform-Powered-by-EOS-Imaging-and-AI/default.aspx ↩ ↩2
-
ATEC Spine, “About ATEC Spine”, corporate product and governance information, accessed 26 October 2026. https://atecspine.com/about/ ↩
-
International Consortium of Investigative Journalists, International Medical Devices Database, Alphatec Spine manufacturer record, historical records associated with 2017. [pre-2020] https://medicaldevices.icij.org/manufacturers/bundesinstitut-fur-arzneimittel-und-medizinprodukte-alphatec-spine ↩ ↩2
-
United Nations, Human Rights Council, sixtieth session, meeting 32, transcript concerning the OHCHR settlement-business database update, 29 September 2025. https://transcripts.un.org/en/hrc/60/32 ↩ ↩2
-
Alphatec Holdings, Inc., “Patrick S. Miles”, official director biography, accessed 26 October 2026. https://investors.alphatecspine.com/governance/board-of-directors/person-details/default.aspx?ItemId=ebbc948f-8aa5-4994-bff5-9c004aaab4d0 ↩
-
Alphatec Holdings, Inc., Definitive Proxy Statement, filed 29 April 2026. https://www.sec.gov/Archives/edgar/data/1350653/000119312526191867/atec-20260429.htm ↩ ↩2
-
Alphatec Holdings, Inc., Form S-8 registration statement, 11 June 2026. https://www.sec.gov/Archives/edgar/data/1350653/000119312526267840/atec-20260611.htm ↩
-
Alphatec Holdings, Inc., official Board of Directors directory, accessed 26 October 2026. https://investors.alphatecspine.com/governance/board-of-directors/default.aspx ↩
-
U.S. Securities and Exchange Commission, Alphatec Holdings, Inc., Form 10-Q filing index, 4 August 2026. https://www.sec.gov/Archives/edgar/data/1350653/000119312526333051/0001193125-26-333051-index.htm ↩
-
U.S. Securities and Exchange Commission, Alphatec Holdings, Inc., fiscal-year 2025 Form 10-K filing index, 24 February 2026. https://www.sec.gov/Archives/edgar/data/1350653/000119312526067393/0001193125-26-067393-index.html ↩ ↩2
-
U.S. Securities and Exchange Commission, Alphatec Holdings, Inc., first-quarter 2026 Form 10-Q filing index, 5 May 2026, reporting period ended 31 March 2026. https://www.sec.gov/Archives/edgar/data/1350653/000119312526206683/0001193125-26-206683-index.htm ↩
-
Alphatec Holdings, Inc., Form 10-Q for quarterly period ended 31 March 2026, filed 5 May 2026, SEC accession 0001193125-26-206683. https://www.sec.gov/Archives/edgar/data/1350653/000119312526206683/atec-20260331.htm ↩ ↩2
-
European Country of Origin Information Network, UN Human Rights Council, “From economy of occupation to economy of genocide”, A/HRC/59/23, document record, 2 July 2025. https://www.ecoi.net/en/document/2126836.html ↩
-
ALPHA TEC, official company website, corporate description of Israeli aesthetic-medicine business, accessed 26 October 2026. https://alphatec.group/en/ ↩
-
U.S. Securities and Exchange Commission, Alphatec Holdings, Inc., 2025 Form 10-K EDGAR submission metadata, filed 24 February 2026. https://www.sec.gov/Archives/edgar/data/1350653/000119312526067393/0001193125-26-067393-index-headers.html ↩